Home Blood Pressure Monitoring Registration Study in the Elderly(HOME Study)

Study Overview
=================
Brief Summary
-----------------
China is entering an aging society. As the number of elderly population continues to increase, the elderly are facing many social problems that deserve the attention of all sectors of society. Hypertension is one of the common diseases in the elderly population. Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. Home blood pressure monitoring is simple, not only can find hypertension, but also can guide the treatment of patients with hypertension. The purpose of the study is to investigate the association between home blood pressure and adverse outcomes in community elderly population.

Detailed Description
-----------------
Study population includes subjects who living in community, of any race or ethnicity, 65 or older years of age, and have provided written informed consent to provide home blood pressure monitoring at one or more study visits. Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of a composite of major adverse cardiovascular events will be investigated during follow-up.

Official Title
-----------------
Home Blood Pressure Registration Study on Community Elderly Population(HOME Study)

Conditions
-----------------
Blood Pressure

Intervention / Treatment
-----------------
* Other: no intervention


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: •≥65 years old Signed informed consent Life expectancy is greater than 1 year Exclusion Criteria: <65 years old Unsigned informed consent

Ages Eligible for Study
-----------------
Minimum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: no intervention|no intervention|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| All-Cause Mortality | All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention. | From date of inclusion until the date of death from any cause, assessed up to 1 year | 
| Cardiovascular Mortality | Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke). | From date of inclusion until the date of death from any cause, assessed up to 1 year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Secondary outcomes of cardiovascular diseases | The number of and the incidence rate of cardiovascular diseases. | Through study completion, an average of 1 years | 
| Secondary outcomes of cerebrovascular diseases | The incidence rate of cerebrovascular diseases. | Through study completion, an average of 1 years | 
| Secondary outcomes of kidney | The incidence rate of renal injure and end-stage renal disease | Through study completion, an average of 1 years | 
| Secondary outcomes of hypertension | The incidence rate of hypertension | Through study completion, an average of 1 years | 
| Secondary outcomes of diabetes | The incidence rate of diabetes | Through study completion, an average of 1 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Elderly, Blood Pressure